학술논문
Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial
Document Type
Article
Author
Laffel, L.M.; Danne, T.; Klingensmith, G.J.; Tamborlane, W.V.; Willi, S.; Zeitler, P.; Neubacher, D.; Marquard, J.; Bardymova, T.; Barrientos Perez, M.; Bethin, K.; Bjornstad, P.; Bondar, I.; Chen, M.; Choi, J.-H.; Clements, M.A.; Colomar, J.R.; Daniels, M.; Deerochanawong, C.; Desai, V.S.; Desmangles, J.-C.G.; Dillon, R.G.; Dixit, N.M.; Du, H.; Edelen, R.; Espinoza Peralta, D.; Felipe Gacioppo, M.V.; Ferraz, T.M.B.L.; Galkina, G.; Gallagher, M.P.; George, M.; Gonzalez, E.; Gottschalk, M.E.; Guido, G.; Hassan, A.A.; Hershkovitz, E.; Huerta-Saenz, L.P.; Hwang, J.S.; Ibarra Gomez, J.O.; Irizarry Gonzalez, L.; Jain, N.; Jelley, D.H.; Kim, H.-S.; Kovalenko, T.; Leichter, S.B.; Liberatore Jr, R.D.R.; Lynch, J.; Mahmud, F.H.; Malievskiy, O.A.; Muir, A.; Nelson, B.A.; Nevarez Ruiz, L.A.; Olson, M.L.; Pelayo Orozco, E.S.; Peterkova, V.; Ramírez Mendoza, F.R.; Reddy, K.M.; Rodriguez, H.; Saenz, J.A.; Samoilova, J.; Schwab, K.-O.; Shah, S.H.; Shehadeh, N.; Shoemaker, A.H.; Skorodok, Y.; Sobolev, A.; Solís, S.E.; Srinivasan, S.; Tsalikian, E.; Valeeva, F.; Vance, C.D.; Velasquez-Mieyer, P.A.; Violante Ortiz, R.M.; Votyakova, O.; Wei, H.; Weinstock, R.S.; Wheeler, M.D.; Wicklow, B.A.; Willi, S.M.; Wintergerst, K.A.; Wolf, R.M.; Wood, J.R.; Yaliwal, C.; Yupanqui Lozno, H.
Source
In: The Lancet Diabetes and Endocrinology . (The Lancet Diabetes and Endocrinology, March 2023, 11(3):169-181)
Subject
Language
English
ISSN
22138595
22138587
22138587